Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype

American Journal of Human Genetics

Volumn 63, Issue 2, 1998, Pages 577-585

  Allayee, Hooman ^a   Aouizerat, Bradley E ^a   Cantor, Rita M ^b   Dallinga Thie, Geesje M ^c   Krauss, Ronald M ^d   Lanning, Christopher D ^b   Rotter, Jerome I ^b   Lusis, Aldons J ^a,f   De Bruin, Tjerk W A ^c,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN C3; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MANGANESE SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; ATHEROGENESIS; CHROMOSOME 11Q; CHROMOSOME 19P; CHROMOSOME 6; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; FAMILIAL DISEASE; FAMILIAL HYPERLIPEMIA; FEMALE; GENE LOCUS; GENETIC LINKAGE; GENOTYPE; HUMAN; HUMAN CELL; HYPERTRIGLYCERIDEMIA; MALE; MARKER GENE; PHENOTYPE; PRIORITY JOURNAL;

EID: 0032231670     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/301983     Document Type: Article

References (36)

1. Amos CI, Elston RC, Wilson AF, Bailey-Wilson JE (1989) A more powerful robust sib-pair test of linkage for quantitative traits. Genet Epidemiol 6:435-449
2. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM (1988a) Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260: 1917-1921
3. Austin MA, Brunzell JD, Fitch WL, Krauss RM (1990a) Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis 10: 520-530
4. Austin MA, King MC, Vranizan KM, Krauss RM (1990b) Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation 82: 495-506
5. Austin MA, King M-C, Vranizan KM, Newman B, Krauss RM (1988b) Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. Am J Hum Genet 43:838-846
6. Bredie SJH, Demacker PNM, Stalenhoef AFH (1997) Metabolic and genetic aspects of familial combined hyperlipidaemia with emphasis on low-density lipoprotein heterogeneity. Eur J Clin Invest 27:802-811
7. Bredie SJH, Kiemeney LA, de Haan AFJ, Demacker PNM, Stalenhoef AFH (1996) Inherited susceptibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia. Am J Hum Genet 58:812-822
8. Brunzell JD, Albers JJ, Chait A, Grundy SM, Grozsek E, McDonald GB (1983) Plasma lipoproteins m familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J Lipid Res 24:147-155
9. Castro Cabezas M, de Bruin TWA, de Valk HA, Shoulders CC, Jansen H, Erkelens DW (1993) Impaired fatty acid metabolism in familial combined hyperlipidemia. J Clin Invest 92:160-168
10. Cortner JA, Coates PM, Bennett MJ, Cryer DR, Le N-A (1991) Familial combined hyperlipidemia: use of stable isotopes to demonstrate overproduction of very low density apolipoprotein B by the liver. J Inherited Metab Dis 14:915-922
11. Cullen P, Farren JS, Farrall M (1994) Complex segregation analysis provides evidence for a major gene acting on serum triglyceride levels in 55 British families with familial combined hyperlipidemia. Arterioscler Thromb 14:1233-1249
12. Dallinga-Thie GM, Bu XD, van Linde-Sibenius Trip M, Rotter JI, Lusis AJ, de Bruin TWA (1996) Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III. J Lipid Res 37:136-147
13. Dallinga-Thie GM, van Linde-Sibenius Trip M, Rotter JI, Cantor RM, Bu X, Lusis AJ, de Bruin TWA (1997) Complex genetic contribution of the apoAI-CIII-AIV gene cluster to familial combined hyperlipidemia. J Clin Invest 99:953-961
14. de Graaf J, Hak-Lemmers HLM, Hectors MPC, Demacker PNM, Hendriks JCM, Stalenhoef AFH (1991) Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 11:298-306
15. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG (1973) Hyperlipidemia in coronary heart disease. II. Genetic analysis in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 52:1544-1568
16. Grundy SM, Chait A, Brunzell JD (1987) Familial combined hyperlipidemia workshop. Arteriosclerosis 7:203-207
17. Haseman JK, Elston RC (1972) The investigation of linkage between a quantitative trait and a marker locus. Behav Genet 2:3-19
18. Jarvik GP, Brunzell JD, Austin MA, Krauss RM, Motulsky AG, Wijsman E (1994) Genetic predictors of FCHL in four large pedigrees: influence of apoB level major locus predicted genotype and LDL subclass phenotype. Arterioscler Thromb 14:1687-1694
19. Kwiterovich PO (1993) Genetic and molecular biology of familial combined hyperlipidemia. Curr Opin Lipidol 4: 133-143
20. Naggert JK, Recinos A III, Lamerdin JE, Krauss RM, Nishina PM (1997) The atherogenic lipoprotein phenotype is not caused by a mutation in the coding region of the low density lipoprotein receptor gene. Clin Genet 51:236-240
21. Nichols AV, Krauss RM, Musliner TA (1986) Nondenaturing polyacrylamide gradient gel electrophoresis. In: Segrest JP, Albers JJ (eds) Methods in enzymology. Vol 128: Plasma lipoproteins, part A: preparation, structure, and molecular biology. Academic Press, Orlando, pp 417-431
22. Nishina PM, Johnson JP, Naggert JK, Krauss RM (1992) Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor on the short arm of chromosome 19. Proc Natl Acad Sci USA 89:708-712
23. Rotter JI, Bu X, Cantor RM, Warden CH, Brown J, Gray RJ, Blanche PJ, et al (1996) Multilocus genetic determinants of LDL particle size in coronary artery disease families. Am J Hum Genet 58:585-594
24. S.A.G.E. (1997) Statistical analysis for genetic epidemiology, ver 3.0. Case Western Reserve University, Cleveland
25. Sakai N, Yamashita S, Hirano K, Menju M, Arai T, Kobayashi K, Ishigami M, et al (1995) Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects. Atherosclerosis 114:139-145
26. Skretting G, Prydz, H (1992) An amino acid exchange in exon 1 of the human lecithin: cholesterol acyltransferase (LCAT) gene is associated with fish eye disease. Biochem Biophys Res Commun 182:583-587
27. Sniderman A, Shapiro S, Marpole D, Skinner B, Teng B, Kwiterovich PO (1980) Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. Proc Natl Acad Sci USA 77:604-608
28. Tall AR (1986) Plasma lipid transfer proteins. J Lipid Res 27: 361-367
29. Tribble DL, Holl LG, Wood PD, Krauss RM (1992) Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis 93:189-199
30. Venkatesan SP, Cullen P, Pacy P, Halliday D, Scott J (1993) Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Arterioscler Thromb 13: 1110-1118
31. Walter MA, Spillett DJ, Thomas P, Weissenbach J, Goodfellow PN (1994) A method for constructing radiation hybrid maps of whole genomes. Nat Genet 7:22-28
32. Weinstock PH, Bisgaier CL, Hayek T, Aalto-Setala K, Schayek E, Wu L, Scheffele P, et al (1997) Decreased HDL cholesterol levels but normal lipid absorption, growth, and feeding behaviour in apolipoprotein A-IV knockout mice. J Lipid Res 38:1782-1794
33. Williams WR, Lalouel JM (1982) Complex segregation analysis of hyperlipidemia in a Seattle sample. Hum Hered 32: 24-36
34. Wojciechowski AP, Farrall M, Cullen P, Wilson T, Bayliss JD, Farren B, Griffin BA, et al (1991) Familial combined hyperlipidemia linked to the apolipoprotein AI-CIII-AIV gene cluster on chromosome 11q23-q24. Nature 349:161-164
35. Wong GH, Elwell JH, Oberley LW, Goeddel DV (1989) Manganese superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58: 923-931
36. Zuliani G, Hobbs HH (1990) Dinucleotide repeat polymorphism at the 3′ end of the LDL receptor gene. Nucleic Acids Res 18:4300